Literature DB >> 16339222

Extra scrutiny for industry funded trials.

Kenneth J Rothman, Stephen Evans.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2005        PMID： 16339222      PMCID： PMC1309629          DOI： 10.1136/bmj.331.7529.1350

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies.

Authors:  Phil B Fontanarosa; Annette Flanagin; Catherine D DeAngelis
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

2.  Conflict of interest. The new McCarthyism in science.

Authors:  K J Rothman
Journal:  JAMA       Date:  1993-06-02       Impact factor: 56.272

3.  Medical journals are an extension of the marketing arm of pharmaceutical companies.

Authors:  Richard Smith
Journal:  PLoS Med       Date:  2005-05-17       Impact factor: 11.069
  3 in total
  7 in total

1.  JAMA's policy on industry sponsored studies.

Authors:  Phil B Fontanarosa; Catherine D DeAngelis
Journal:  BMJ       Date:  2006-01-21

2.  Response to AMA's Council on Ethical and Judicial Affairs draft report on "Ethical guidance for physicians and the profession with respect to industry support for professional education in medicine".

Authors:  Thomas P Stossel
Journal:  Medscape J Med       Date:  2008-06-12

3.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.

Authors:  Laurence J Hirsch
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

4.  Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?

Authors:  William L Lanier
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

5.  JAMA published fewer industry-funded studies after introducing a requirement for independent statistical analysis.

Authors:  Elizabeth Wager; Rahul Mhaskar; Stephanie Warburton; Benjamin Djulbegovic
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

6.  Taking financial relationships into account when assessing research.

Authors:  David B Resnik; Kevin C Elliott
Journal:  Account Res       Date:  2013       Impact factor: 2.622

Review 7.  Industry funding and the reporting quality of large long-term weight loss trials.

Authors:  O Thomas; L Thabane; J Douketis; R Chu; A O Westfall; D B Allison
Journal:  Int J Obes (Lond)       Date:  2008-08-19       Impact factor: 5.095
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.